Innovative Device Bringing Relief to PTSD Victims

This week’s startup developed a science-backed, screen-free biofeedback device, already trusted by thousands of users and a Fortune 500 health-insurance giant. They are also partnering with local organizations in Israel to help mitigate PTSD effects for IDF veterans and October 7 victims. 

Company name: Reflect Innovation

Website: meetreflect.com

What they do (in a sentence):
Reflect created the Orb - an innovative, patented device tackling mental health, anxiety and PTSD. 

Why now:

• Mental health conditions are accelerating worldwide, yet >50 % of those who need care still lack access or avoid therapy due to stigma.

• Employers and insurers are urgently seeking scalable, cost-effective solutions, while digital therapeutics and personalized, data-driven interventions are gaining mainstream adoption.

• Advances in compact biosensors and AI allow Reflect to deliver lab-quality insights and adaptive coaching in a mass-market product.

Team highlights:

• Noga Sapir (co-founder & CEO) - neuroscience & textile-design background. Driven to build Reflect out of her lived experience with anxiety.

• Ron Sneh (CTO) - 10+ years building hardware–software neurotech platforms; published research on self-regulation and emotional processing.

• Dr. Michal Gruberger (Chief Scientist) - a leading neuroscientist and neuropsychologist

• An advisory board of leading clinicians and researchers in biofeedback and behavioral health.

Traction:

• Over 3000 Reflect Orbs sold D2C; thousands of therapy patients and self-regulating users.

• Five-year commercial partnership signed with health-insurance giant Cigna Healthcare, opening enterprise healthcare, government, and education channels (initial orders in progress).

• Product integrated into clinical studies, therapist practices, school resilience programs, and a post-war reservist-reintegration retreat.

Competitive edge/moats:

• Patented signal-processing algorithms for high-fidelity EDA/ECG in a handheld form factor; multiple design & R&D patents issued in the US, EU, Israel, China, and Japan.

• Deep clinical integrations and insurer partnerships create high switching costs and proprietary datasets that continuously improve outcomes.

Capital raised: $7M to date

Notable investors: CNS Fund

Contact: To explore investment or partnership opportunities, reach out to Noga Sapir (CEO), or request an introduction by replying to this message.

Last week, 83% of all voters said MyPraxis has exciting potential.

What do you think about Reflect Innovation?

Cast your vote now:

***

That’s all for today.

Yours,

Tzakhi and the Chosen.Ventures team

PS Let’s connect:

1. If you invest or are looking to invest in Israeli startups, let’s talk. Reply to this email or go ahead and book a time with me on my Calendly. Thanks.

2. If you are in touch with Israeli startups you believe we should feature, let them know about us or introduce them to me. They can also apply here (there is no cost to getting featured).

3. If you would like to partner, sponsor, or collaborate with us in any way, send me a message by replying to this email.

* Disclaimer: The information we share in our emails and on our website is solely for entertainment purposes and should never be considered investment or financial advice. The startups we feature provide us with the information we share about them, and they are solely responsible for its accuracy. The startups we feature may have business and other connections with us or our affiliates.